Profilo
David Picard is the founder of Moleac Pte Ltd., founded in 2003, where the title held is Chief Executive Officer & Director since 2012.
Mr. Picard is also the founder of Pharnext SA..
Mr. Picard was Principal at The Boston Consulting Group, Inc. Mr. Picard completed undergraduate degrees at Ecole Polytechnique and École Nationale Supérieure des Mines de Paris.
Posizioni attive di David Picard
| Società | Posizione | Inizio |
|---|---|---|
Moleac Pte Ltd.
Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops and distributes biopharmaceutical products | Fondatore | 15/12/2009 |
Precedenti posizioni note di David Picard
| Società | Posizione | Fine |
|---|---|---|
| PHARNEXT SCA | Fondatore | - |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Corporate Officer/Principal | - |
Formazione di David Picard
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Moleac Pte Ltd.
Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops and distributes biopharmaceutical products | Health Technology |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Ecole Polytechnique
Ecole Polytechnique Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
École Nationale Supérieure des Mines de Paris
École Nationale Supérieure des Mines de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharnext SA
Pharnext SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies for patients to treat neurodegenerative diseases | Health Technology |
















